Broker Tips
Jefferies reiterates 'buy' on Centrica but concedes downside risks to consensus view
Analysts at Jefferies reiterated their buy recommendation and 165p target price on shares of Centrica following the energy's supplier's latest interims, even as they conceded that several aspects of the group's results "implied" downside risks to consensus estimates for its earnings per share in fiscal year 2018.
Broker tips: Centrica, Abcam
Analysts at Jefferies reiterated their buy recommendation and 165p target price on shares of Centrica following the energy's supplier's latest interims, even as they conceded that several aspects of the group's results "implied" downside risks to consensus estimates for its earnings per share in fiscal year 2018.
Berenberg changes mind on Abcam, reinstating 'buy' rating
Analysts at Berenberg on Tuesday upgraded their rating for shares of Abcam from ‘Hold’ to ‘Buy’ after having downgraded shares of the antibodies supplier just three months ago.
